Aberdeen Group Portfolio holdings
AUM
$58.8B
1-Year Return
21.66%
This Quarter Return
-3.36%
1 Year Return
+21.66%
3 Year Return
+94.43%
5 Year Return
+162.75%
10 Year Return
–
AUM
$51.3B
AUM Growth
-$1.99B
(-3.7%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
2.4%
Top 10 Holdings %
Top 10 Hldgs %
31.61%
Holding
975
New
44
Increased
561
Reduced
289
Closed
33
Top Buys
| 1 |
Apple
AAPL
|
+$698M |
| 2 |
Tesla
TSLA
|
+$436M |
| 3 |
Amazon
AMZN
|
+$435M |
| 4 |
Microsoft
MSFT
|
+$342M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$295M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$216M |
| 2 |
Coca-Cola
KO
|
+$207M |
| 3 |
Gilead Sciences
GILD
|
+$205M |
| 4 |
Ecolab
ECL
|
+$199M |
| 5 |
Equinix
EQIX
|
+$187M |
Sector Composition
| 1 | Technology | 29.31% |
| 2 | Healthcare | 15.26% |
| 3 | Consumer Discretionary | 11.25% |
| 4 | Financials | 10.95% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Ally Financial
ALLY
$12.7B
| $7.59M | 0.01% |
208,179
-61,785
| -23% | -$2.25M |
|
627
Exact Sciences
EXAS
$10.2B
| $7.47M | 0.01% |
172,565
+110,924
| +180% | +$4.8M |
|
628
Axsome Therapeutics
AXSM
$6.45B
| $7.46M | 0.01% |
63,954
-8,225
| -11% | -$959K |
|
629
Fox Class A
FOXA
$27.8B
| $7.39M | 0.01% |
132,674
+76,079
| +134% | +$4.24M |
|
|
GRAL
630
GRAIL, Inc. Common Stock
GRAL
$1.38B
| $7.27M | 0.01% |
284,735
+73,667
| +35% | +$1.88M |
|
631
CF Industries
CF
$13.7B
| $7.25M | 0.01% |
93,308
+53,949
| +137% | +$4.19M |
|
632
Merus
MRUS
$5.08B
| $7.24M | 0.01% |
172,063
+84,848
| +97% | +$3.57M |
|
633
IDEAYA Biosciences
IDYA
$2.05B
| $7.23M | 0.01% |
441,305
+134,582
| +44% | +$2.2M |
|
634
Futu Holdings
FUTU
$26.1B
| $7.21M | 0.01% |
71,497
+6,327
| +10% | +$638K |
|
635
Vipshop
VIPS
$8.58B
| $7.2M | 0.01% |
459,070
-264,269
| -37% | -$4.14M |
|
636
Infosys
INFY
$69.6B
| $7.15M | 0.01% |
397,150
+56,386
| +17% | +$1.02M |
|
637
Avantor
AVTR
$8.95B
| $7.06M | 0.01% |
435,622
-240,546
| -36% | -$3.9M |
|
638
Crinetics Pharmaceuticals
CRNX
$3.31B
| $6.98M | 0.01% |
208,059
+164,670
| +380% | +$5.52M |
|
639
Zillow
Z
$21.8B
| $6.97M | 0.01% |
101,703
+56,025
| +123% | +$3.84M |
|
640
EPAM Systems
EPAM
$9.16B
| $6.96M | 0.01% |
41,831
+16,058
| +62% | +$2.67M |
|
641
Edgewise Therapeutics
EWTX
$1.57B
| $6.89M | 0.01% |
313,025
+134,982
| +76% | +$2.97M |
|
642
Annaly Capital Management
NLY
$14.2B
| $6.84M | 0.01% |
340,272
+190,215
| +127% | +$3.82M |
|
643
Tandem Diabetes Care
TNDM
$845M
| $6.83M | 0.01% |
356,218
+107,354
| +43% | +$2.06M |
|
644
Halozyme
HALO
$8.87B
| $6.81M | 0.01% |
106,737
-21,933
| -17% | -$1.4M |
|
645
Krystal Biotech
KRYS
$4.2B
| $6.73M | 0.01% |
37,301
-19,732
| -35% | -$3.56M |
|
646
Northrop Grumman
NOC
$83.3B
| $6.7M | 0.01% |
13,120
+109
| +0.8% | +$55.7K |
|
647
iShares MSCI Taiwan ETF
EWT
$6.33B
| $6.67M | 0.01% |
141,606
-17,000
| -11% | -$801K |
|
648
Royalty Pharma
RPRX
$15.5B
| $6.59M | 0.01% |
213,860
+124,193
| +139% | +$3.83M |
|
649
Lennar Class A
LEN
$36.9B
| $6.59M | 0.01% |
58,024
-2,012
| -3% | -$228K |
|
650
United Airlines
UAL
$34.9B
| $6.57M | 0.01% |
96,675
+38,981
| +68% | +$2.65M |
|